nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—hypertension—focal segmental glomerulosclerosis	0.409	1	CtDrD
Losartan—AGTR1—focal segmental glomerulosclerosis	0.189	0.551	CbGaD
Losartan—ACE—focal segmental glomerulosclerosis	0.109	0.318	CbGaD
Losartan—ALB—focal segmental glomerulosclerosis	0.0447	0.13	CbGaD
Losartan—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.0436	0.277	CbGbCtD
Losartan—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0281	0.178	CbGbCtD
Losartan—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0192	0.122	CbGbCtD
Losartan—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0185	0.117	CbGbCtD
Losartan—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0982	CbGbCtD
Losartan—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0817	CbGbCtD
Losartan—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0792	CbGbCtD
Losartan—SLC22A12—nephron—focal segmental glomerulosclerosis	0.0101	0.213	CbGeAlD
Losartan—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.00749	0.0475	CbGbCtD
Losartan—SLC2A9—nephron—focal segmental glomerulosclerosis	0.00697	0.146	CbGeAlD
Losartan—ACE—arteriole—focal segmental glomerulosclerosis	0.00453	0.095	CbGeAlD
Losartan—AGTR1—nephron—focal segmental glomerulosclerosis	0.00267	0.056	CbGeAlD
Losartan—SLC22A12—nephron tubule—focal segmental glomerulosclerosis	0.00219	0.0459	CbGeAlD
Losartan—ACE—nephron—focal segmental glomerulosclerosis	0.00197	0.0413	CbGeAlD
Losartan—SLC22A12—kidney—focal segmental glomerulosclerosis	0.00192	0.0403	CbGeAlD
Losartan—SLC22A12—cortex of kidney—focal segmental glomerulosclerosis	0.00187	0.0393	CbGeAlD
Losartan—UGT1A10—kidney—focal segmental glomerulosclerosis	0.00169	0.0354	CbGeAlD
Losartan—SLC2A9—nephron tubule—focal segmental glomerulosclerosis	0.0015	0.0315	CbGeAlD
Losartan—SLC2A9—kidney—focal segmental glomerulosclerosis	0.00132	0.0277	CbGeAlD
Losartan—SLC2A9—cortex of kidney—focal segmental glomerulosclerosis	0.00129	0.027	CbGeAlD
Losartan—AGTR1—endothelium—focal segmental glomerulosclerosis	0.00126	0.0264	CbGeAlD
Losartan—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0424	CcSEcCtD
Losartan—Tasosartan—AGTR2—focal segmental glomerulosclerosis	0.000954	0.213	CrCbGaD
Losartan—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.000943	0.0339	CcSEcCtD
Losartan—ACE—endothelium—focal segmental glomerulosclerosis	0.000929	0.0195	CbGeAlD
Losartan—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.0329	CcSEcCtD
Losartan—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.0262	CcSEcCtD
Losartan—Eprosartan—AGTR1—focal segmental glomerulosclerosis	0.00072	0.161	CrCbGaD
Losartan—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.000713	0.015	CbGeAlD
Losartan—UGT2B7—kidney—focal segmental glomerulosclerosis	0.000682	0.0143	CbGeAlD
Losartan—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00061	0.0128	CbGeAlD
Losartan—Azilsartan medoxomil—AGTR1—focal segmental glomerulosclerosis	0.000587	0.131	CrCbGaD
Losartan—UGT1A1—kidney—focal segmental glomerulosclerosis	0.00058	0.0122	CbGeAlD
Losartan—AGTR1—nephron tubule—focal segmental glomerulosclerosis	0.000576	0.0121	CbGeAlD
Losartan—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.0199	CcSEcCtD
Losartan—Forasartan—AGTR1—focal segmental glomerulosclerosis	0.000545	0.122	CrCbGaD
Losartan—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.0182	CcSEcCtD
Losartan—AGTR1—kidney—focal segmental glomerulosclerosis	0.000506	0.0106	CbGeAlD
Losartan—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0005	0.018	CcSEcCtD
Losartan—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.0177	CcSEcCtD
Losartan—AGTR1—cortex of kidney—focal segmental glomerulosclerosis	0.000493	0.0103	CbGeAlD
Losartan—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.0174	CcSEcCtD
Losartan—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.0174	CcSEcCtD
Losartan—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.000483	0.0101	CbGeAlD
Losartan—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.0173	CcSEcCtD
Losartan—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.000472	0.0169	CcSEcCtD
Losartan—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.0164	CcSEcCtD
Losartan—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.0158	CcSEcCtD
Losartan—ACE—nephron tubule—focal segmental glomerulosclerosis	0.000426	0.00892	CbGeAlD
Losartan—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000424	0.0152	CcSEcCtD
Losartan—ACE—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000386	0.037	CbGpPWpGaD
Losartan—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000375	0.0135	CcSEcCtD
Losartan—ACE—kidney—focal segmental glomerulosclerosis	0.000374	0.00784	CbGeAlD
Losartan—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.0131	CcSEcCtD
Losartan—ACE—cortex of kidney—focal segmental glomerulosclerosis	0.000364	0.00764	CbGeAlD
Losartan—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.0127	CcSEcCtD
Losartan—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.0126	CcSEcCtD
Losartan—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.0123	CcSEcCtD
Losartan—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.0121	CcSEcCtD
Losartan—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.012	CcSEcCtD
Losartan—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.012	CcSEcCtD
Losartan—Tasosartan—AGTR1—focal segmental glomerulosclerosis	0.00033	0.0739	CrCbGaD
Losartan—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.0116	CcSEcCtD
Losartan—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.0115	CcSEcCtD
Losartan—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000305	0.011	CcSEcCtD
Losartan—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000299	0.0107	CcSEcCtD
Losartan—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.0106	CcSEcCtD
Losartan—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.0105	CcSEcCtD
Losartan—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.0104	CcSEcCtD
Losartan—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.0103	CcSEcCtD
Losartan—Valsartan—AGTR1—focal segmental glomerulosclerosis	0.000287	0.0641	CrCbGaD
Losartan—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000282	0.00591	CbGeAlD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.000282	0.027	CbGpPWpGaD
Losartan—Olmesartan—AGTR1—focal segmental glomerulosclerosis	0.000279	0.0624	CrCbGaD
Losartan—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00991	CcSEcCtD
Losartan—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000275	0.00576	CbGeAlD
Losartan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00973	CcSEcCtD
Losartan—Telmisartan—AGTR1—focal segmental glomerulosclerosis	0.000269	0.0602	CrCbGaD
Losartan—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.0094	CcSEcCtD
Losartan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00934	CcSEcCtD
Losartan—AGTR1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000258	0.0247	CbGpPWpGaD
Losartan—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000256	0.0092	CcSEcCtD
Losartan—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000254	0.00912	CcSEcCtD
Losartan—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00907	CcSEcCtD
Losartan—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000248	0.0052	CbGeAlD
Losartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000248	0.0238	CbGpPWpGaD
Losartan—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00886	CcSEcCtD
Losartan—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00884	CcSEcCtD
Losartan—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.00879	CcSEcCtD
Losartan—SLCO1B3—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000244	0.0234	CbGpPWpGaD
Losartan—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000244	0.00876	CcSEcCtD
Losartan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000244	0.00876	CcSEcCtD
Losartan—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000241	0.00506	CbGeAlD
Losartan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.0085	CcSEcCtD
Losartan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00846	CcSEcCtD
Losartan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000226	0.00811	CcSEcCtD
Losartan—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000225	0.00809	CcSEcCtD
Losartan—AGTR1—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.000225	0.0215	CbGpPWpGaD
Losartan—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000224	0.00805	CcSEcCtD
Losartan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000224	0.00803	CcSEcCtD
Losartan—Candesartan—AGTR1—focal segmental glomerulosclerosis	0.000217	0.0485	CrCbGaD
Losartan—Irbesartan—AGTR1—focal segmental glomerulosclerosis	0.000217	0.0485	CrCbGaD
Losartan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00755	CcSEcCtD
Losartan—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00751	CcSEcCtD
Losartan—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00734	CcSEcCtD
Losartan—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00723	CcSEcCtD
Losartan—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00715	CcSEcCtD
Losartan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00694	CcSEcCtD
Losartan—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00691	CcSEcCtD
Losartan—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.0069	CcSEcCtD
Losartan—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00684	CcSEcCtD
Losartan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00677	CcSEcCtD
Losartan—ACE—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000187	0.018	CbGpPWpGaD
Losartan—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000186	0.0039	CbGeAlD
Losartan—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000185	0.00664	CcSEcCtD
Losartan—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000184	0.0066	CcSEcCtD
Losartan—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00654	CcSEcCtD
Losartan—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.00651	CcSEcCtD
Losartan—SLCO1B3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000181	0.0174	CbGpPWpGaD
Losartan—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00647	CcSEcCtD
Losartan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00644	CcSEcCtD
Losartan—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00635	CcSEcCtD
Losartan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00633	CcSEcCtD
Losartan—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00631	CcSEcCtD
Losartan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.00615	CcSEcCtD
Losartan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.006	CcSEcCtD
Losartan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.006	CcSEcCtD
Losartan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.006	CcSEcCtD
Losartan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00598	CcSEcCtD
Losartan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00593	CcSEcCtD
Losartan—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000164	0.0157	CbGpPWpGaD
Losartan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00587	CcSEcCtD
Losartan—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000161	0.0058	CcSEcCtD
Losartan—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.00575	CcSEcCtD
Losartan—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.00575	CcSEcCtD
Losartan—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.00571	CcSEcCtD
Losartan—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000157	0.00564	CcSEcCtD
Losartan—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000157	0.00563	CcSEcCtD
Losartan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.00556	CcSEcCtD
Losartan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00548	CcSEcCtD
Losartan—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00015	0.00314	CbGeAlD
Losartan—AGTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.000147	0.0141	CbGpPWpGaD
Losartan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00524	CcSEcCtD
Losartan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.0052	CcSEcCtD
Losartan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.00516	CcSEcCtD
Losartan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.00513	CcSEcCtD
Losartan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000142	0.00511	CcSEcCtD
Losartan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00506	CcSEcCtD
Losartan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.005	CcSEcCtD
Losartan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00496	CcSEcCtD
Losartan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000137	0.00492	CcSEcCtD
Losartan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000137	0.00492	CcSEcCtD
Losartan—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000132	0.00474	CcSEcCtD
Losartan—ABCB1—kidney—focal segmental glomerulosclerosis	0.000132	0.00276	CbGeAlD
Losartan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000131	0.0047	CcSEcCtD
Losartan—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000128	0.00269	CbGeAlD
Losartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000128	0.0122	CbGpPWpGaD
Losartan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000127	0.00457	CcSEcCtD
Losartan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000127	0.00455	CcSEcCtD
Losartan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000127	0.00455	CcSEcCtD
Losartan—AGTR1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000125	0.012	CbGpPWpGaD
Losartan—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000122	0.0117	CbGpPWpGaD
Losartan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00424	CcSEcCtD
Losartan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000115	0.00413	CcSEcCtD
Losartan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000113	0.00407	CcSEcCtD
Losartan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00011	0.00393	CcSEcCtD
Losartan—ACE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000107	0.0102	CbGpPWpGaD
Losartan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.0038	CcSEcCtD
Losartan—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000105	0.0101	CbGpPWpGaD
Losartan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000102	0.00366	CcSEcCtD
Losartan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.00363	CcSEcCtD
Losartan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.00362	CcSEcCtD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.0001	0.00963	CbGpPWpGaD
Losartan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.0001	0.0036	CcSEcCtD
Losartan—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	9.68e-05	0.00929	CbGpPWpGaD
Losartan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	9.51e-05	0.00342	CcSEcCtD
Losartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	9.46e-05	0.00908	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	9.22e-05	0.00885	CbGpPWpGaD
Losartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	9.06e-05	0.00869	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	8.98e-05	0.00861	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	8.51e-05	0.00817	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.83e-05	0.00751	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.16e-05	0.00687	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	7.03e-05	0.00674	CbGpPWpGaD
Losartan—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	6.97e-05	0.00669	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	6.9e-05	0.00662	CbGpPWpGaD
Losartan—Valsartan—ALB—focal segmental glomerulosclerosis	6.78e-05	0.0152	CrCbGaD
Losartan—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	6.4e-05	0.00614	CbGpPWpGaD
Losartan—SLC2A9—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.39e-05	0.00613	CbGpPWpGaD
Losartan—SLC2A9—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	6.36e-05	0.0061	CbGpPWpGaD
Losartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	6.36e-05	0.0061	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	6.29e-05	0.00603	CbGpPWpGaD
Losartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	6.09e-05	0.00584	CbGpPWpGaD
Losartan—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	6.09e-05	0.00584	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	5.88e-05	0.00564	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	5.82e-05	0.00558	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	5.4e-05	0.00518	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	5.26e-05	0.00504	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	5.22e-05	0.00501	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—LIPC—focal segmental glomerulosclerosis	4.99e-05	0.00478	CbGpPWpGaD
Losartan—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	4.74e-05	0.00455	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	4.63e-05	0.00444	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	4.56e-05	0.00437	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	4.5e-05	0.00432	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CTGF—focal segmental glomerulosclerosis	4.39e-05	0.00421	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	4.29e-05	0.00412	CbGpPWpGaD
Losartan—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	4.25e-05	0.00408	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	4.08e-05	0.00391	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.05e-05	0.00388	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	3.78e-05	0.00363	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	3.73e-05	0.00358	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	3.66e-05	0.00351	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	3.61e-05	0.00346	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	3.55e-05	0.00341	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	3.53e-05	0.00338	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	3.38e-05	0.00325	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.23e-05	0.0031	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	3.18e-05	0.00305	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	3.14e-05	0.00302	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	3.08e-05	0.00295	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—LPL—focal segmental glomerulosclerosis	3.04e-05	0.00292	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	3.02e-05	0.0029	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.96e-05	0.00284	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	2.75e-05	0.00264	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	2.63e-05	0.00253	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—AGT—focal segmental glomerulosclerosis	2.6e-05	0.0025	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.6e-05	0.00249	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	2.51e-05	0.0024	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.4e-05	0.0023	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	2.35e-05	0.00225	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	2.33e-05	0.00224	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	2.31e-05	0.00222	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	2.3e-05	0.0022	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.29e-05	0.00219	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	2.24e-05	0.00215	CbGpPWpGaD
Losartan—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	2.21e-05	0.00212	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	2.2e-05	0.00211	CbGpPWpGaD
Losartan—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.07e-05	0.00199	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	2.06e-05	0.00198	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.01e-05	0.00193	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2e-05	0.00192	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—ALB—focal segmental glomerulosclerosis	2e-05	0.00192	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.99e-05	0.00191	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	1.96e-05	0.00188	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.95e-05	0.00187	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	1.92e-05	0.00184	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.91e-05	0.00183	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.88e-05	0.00181	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	1.83e-05	0.00176	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.82e-05	0.00175	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.81e-05	0.00174	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	1.78e-05	0.00171	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.77e-05	0.0017	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.76e-05	0.00169	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.74e-05	0.00167	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.73e-05	0.00166	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	1.72e-05	0.00165	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.68e-05	0.00161	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.61e-05	0.00154	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.58e-05	0.00152	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	1.58e-05	0.00151	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.54e-05	0.00147	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.52e-05	0.00146	CbGpPWpGaD
Losartan—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	1.48e-05	0.00142	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.46e-05	0.0014	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.44e-05	0.00138	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.43e-05	0.00137	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.36e-05	0.0013	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	1.32e-05	0.00127	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.31e-05	0.00125	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.3e-05	0.00125	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.23e-05	0.00118	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	1.21e-05	0.00116	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.19e-05	0.00114	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.18e-05	0.00113	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.16e-05	0.00111	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	1.16e-05	0.00111	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.08e-05	0.00104	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.08e-05	0.00103	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.07e-05	0.00103	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.07e-05	0.00103	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.07e-05	0.00103	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.06e-05	0.00102	CbGpPWpGaD
Losartan—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	1.06e-05	0.00102	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.04e-05	0.001	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.04e-05	0.000997	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	1.02e-05	0.000983	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.02e-05	0.000976	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1e-05	0.000961	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.96e-06	0.000956	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.95e-06	0.000954	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.89e-06	0.000948	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.79e-06	0.000939	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.38e-06	0.000899	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.19e-06	0.000882	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	9.18e-06	0.000881	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.11e-06	0.000873	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.99e-06	0.000862	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.95e-06	0.000858	CbGpPWpGaD
Losartan—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	8.88e-06	0.000852	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.82e-06	0.000846	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.77e-06	0.000841	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	8.52e-06	0.000818	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.48e-06	0.000813	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.46e-06	0.000812	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.16e-06	0.000782	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.06e-06	0.000773	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.88e-06	0.000755	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.77e-06	0.000745	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	7.49e-06	0.000718	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.46e-06	0.000716	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.3e-06	0.0007	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.18e-06	0.000689	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—LPL—focal segmental glomerulosclerosis	7.05e-06	0.000677	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.99e-06	0.00067	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.97e-06	0.000669	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.97e-06	0.000668	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.88e-06	0.000659	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.84e-06	0.000656	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.76e-06	0.000648	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.64e-06	0.000637	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	6.4e-06	0.000614	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.4e-06	0.000614	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	6.37e-06	0.000611	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.3e-06	0.000604	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.14e-06	0.000589	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.12e-06	0.000587	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.08e-06	0.000583	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AGT—focal segmental glomerulosclerosis	6.04e-06	0.000579	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.78e-06	0.000555	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.46e-06	0.000524	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	5.45e-06	0.000522	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	5.38e-06	0.000516	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.34e-06	0.000513	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	5.3e-06	0.000508	CbGpPWpGaD
Losartan—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	5.28e-06	0.000506	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.23e-06	0.000502	CbGpPWpGaD
Losartan—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	5.22e-06	0.0005	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.2e-06	0.000499	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	5.17e-06	0.000496	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	5.15e-06	0.000494	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.98e-06	0.000477	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	4.91e-06	0.000471	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	4.74e-06	0.000455	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.67e-06	0.000448	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ALB—focal segmental glomerulosclerosis	4.63e-06	0.000444	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	4.54e-06	0.000435	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	4.46e-06	0.000428	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.45e-06	0.000427	CbGpPWpGaD
Losartan—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	4.44e-06	0.000426	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	4.43e-06	0.000424	CbGpPWpGaD
Losartan—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	4.39e-06	0.000421	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.26e-06	0.000408	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.25e-06	0.000408	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.18e-06	0.000401	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	4.18e-06	0.000401	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	4.05e-06	0.000389	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.01e-06	0.000385	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	3.98e-06	0.000382	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	3.93e-06	0.000377	CbGpPWpGaD
Losartan—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	3.91e-06	0.000375	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.89e-06	0.000373	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.64e-06	0.000349	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.63e-06	0.000348	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.62e-06	0.000347	CbGpPWpGaD
Losartan—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.6e-06	0.000345	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.58e-06	0.000344	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	3.51e-06	0.000336	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.42e-06	0.000328	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.41e-06	0.000327	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	3.4e-06	0.000326	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.33e-06	0.000319	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.27e-06	0.000313	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.23e-06	0.00031	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.2e-06	0.000307	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.15e-06	0.000303	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	3.14e-06	0.000302	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	3.11e-06	0.000298	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.1e-06	0.000298	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.95e-06	0.000283	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.81e-06	0.000269	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.79e-06	0.000268	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.77e-06	0.000266	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.73e-06	0.000262	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	2.72e-06	0.000261	CbGpPWpGaD
Losartan—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	2.71e-06	0.00026	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	2.69e-06	0.000258	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.52e-06	0.000242	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	2.43e-06	0.000233	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.4e-06	0.00023	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.37e-06	0.000228	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.33e-06	0.000223	CbGpPWpGaD
Losartan—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	2.32e-06	0.000222	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.22e-06	0.000213	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.11e-06	0.000202	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.08e-06	0.000199	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	2.06e-06	0.000198	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.03e-06	0.000195	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.94e-06	0.000186	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.9e-06	0.000182	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.89e-06	0.000182	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.79e-06	0.000172	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.62e-06	0.000155	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.6e-06	0.000153	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.56e-06	0.000149	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.46e-06	0.00014	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.46e-06	0.00014	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.25e-06	0.00012	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.24e-06	0.000119	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	9.6e-07	9.21e-05	CbGpPWpGaD
